Webcast: Optimizing LDL-C Management Post-MI: Patient Case & Expert Discussions |
- 1.00 CDE
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
|
Enduring |
|
$0.00 |
A Shifting Paradigm: Translating Research into Treatment Approaches for ALS |
- 1.00 ACCME (MD/DO Only)
- 1.00 ACCME (All Other)
- 1.00 ACPE Pharmacy
- 1.00 ANCC
|
Enduring |
|
$0.00 |
17th Annual Cardiometabolic Health Congress On-Demand |
- 18.50 CDE
- 18.50 ABIM MOC and AMA PRA Category 1 Credit™
- 18.50 ACPE Pharmacy
- 18.50 AMA PRA Category 1 Credit™
- 18.50 ANCC
- 18.50 Participation
|
Enduring |
|
$0.00 |
Clinical Spotlight: Pediatric Diagnosis & Treatment for Rett Syndrome |
- 1.25 AMA PRA Category 1 Credit™
- 1.25 ANCC
- 1.25 Participation
|
Enduring |
|
$0.00 |
Overwhelmed and Underdiagnosed: Understanding ADHD in Female Patients |
- 1.00 ACCME (MD/DO Only)
- 1.00 ACCME (All Other)
- 1.00 ACPE Pharmacy
- 1.00 ANCC
|
Enduring |
|
$0.00 |
A Closer Look: CDKL5 Deficiency Disorder & Rescue Treatment |
- 0.25 ACCME (MD/DO Only)
- 0.25 ACCME (All Other)
- 0.25 ACPE Pharmacy
- 0.25 ANCC
|
Enduring |
|
$0.00 |
Hunting for Better Outcomes: Management Options for Huntington’s Disease |
- 0.50 ACCME (MD/DO Only)
- 0.50 ACCME (All Other)
- 0.50 ACPE Pharmacy
- 0.50 ANCC
|
Enduring |
|
$0.00 |
Virtual Symposium - Assessing the Evolving Role of GLP1-RAs to Reduce Cardiovascular Risk: Emerging Evidence, Evolving Guidance, and Expert... |
- 1.00 CDE
- 1.00 ABIM MOC and AMA PRA Category 1 Credit™
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
|
Enduring |
|
$0.00 |
Primer: Gamechangers in Alopecia Areata: Targeted Therapies for Patient-Centered Care |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
|
Enduring |
|
$0.00 |
The Disproportionate Burden of Heart Failure in Women: Advances & Expert Perspectives to Improve Diagnosis & Treatment |
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
|
Enduring |
|
$0.00 |
Virtual Symposium - Escaping the Current Gaps in the Understanding and Treatment of CKD Anemia: Making Sense of Emerging Therapies |
- 1.00 CDE
- 1.00 ABIM MOC and AMA PRA Category 1 Credit™
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
|
Enduring |
|
$0.00 |
Virtual Symposium: What You Need to Know About Optimizing Cardiorenal Outcomes with Novel NonSteroidal MRAs |
- 1.50 ACPE Pharmacy
- 1.50 AMA PRA Category 1 Credit™
- 1.50 ANCC
- 1.50 Participation
|
Enduring |
|
$0.00 |
Clinical Brief: Why Should We Use CGM in Patients With Type 2 Diabetes? Assessing the Evidence and Practical Pearls for Integration |
- 0.50 CDE
- 0.50 ABIM MOC and AMA PRA Category 1 Credit™
- 0.50 ACPE Pharmacy
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC
- 0.50 Participation
|
Enduring |
|
$0.00 |
Making Sense of LDL-C Combination Therapy in 2022: Strategies and Pearls to Move Beyond Inertia to Improve Patient Outcomes |
- 1.25 CDE
- 1.25 ABIM MOC and AMA PRA Category 1 Credit™
- 1.25 ACPE Pharmacy
- 1.25 AMA PRA Category 1 Credit™
- 1.25 ANCC
- 1.25 Participation
|
Enduring |
|
$0.00 |
Navigating the Diagnosis and Treatment of Patients with Narcolepsy and Cardiovascular Risk |
- 1.50 CDE
- 1.50 ABIM MOC and AMA PRA Category 1 Credit™
- 1.50 ACPE Pharmacy
- 1.50 AMA PRA Category 1 Credit™
- 1.50 ANCC
- 1.50 Participation
|
Enduring |
|
$0.00 |